Quotient Clinical acquires QS Pharma from Charles River Laboratories International, Inc.

London, UK – GHO Capital, the European specialist investor in healthcare, is pleased to share today’s announcement from its portfolio company Quotient Clinical regarding its acquisition of QS Pharma, increasing its US presence and adding high potency molecule capabilities to its existing operations. Addition of contract development and manufacturing organisation increases scale of business and… read more

Subscribe to our email alerts

Email updates